Reduces the risk of cardiovascular events in diabetes patients with heart disease
Exenatide IR (immediate-release) is given twice daily, while exenatide ER is a once-weekly microsphere formulation
"These GLP-1 agonists can be a two-in-one solution for diabetes and weight loss," Robert Fontana, MD, a Michigan Medicine hepatologist said in an online interview included in the Cure report, "maybe a three-in-one solution if they prove to be safe and effective for metabolic associated steatohepatitis as well." Troubling Pattern in Patient Adherence to GLP-1 Drug Therapy Despite their effectiveness, adhering to the injectable drugs have proven challenging
Li Y, Xiang Q, Zhang Q, Huang Y, Su Z
Reduced glutathione color coded according to its constituent amino acids: pink, glutamate